hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 10:37:08 - browse：64

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Snackable artificial intelligence, expert AI, and the pharma industry

focus

WSS

Listen: Vivek Ramaswamy's star turn & leaky drug data

People can get long Covid without testing positive for virus: Study

How generative AI is inspiring dreams of a health data revolution

California store owner shot dead in dispute over displaying Pride flag: Police

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Snackable artificial intelligence, expert AI, and the pharma industry

Wikipedia

hotspot

Wikipedia

At least 13 dead in Texas as scorching temps continue

Kellogg’s is going to war over Mexico’s nutrition label rules

Malaria cases in Florida and Texas: Here’s what you need to know

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

ChatGPT in medicine: STAT answers readers' burning questions

AstraZeneca chief proposes a novel edit to the drug pricing bill

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A new House health package & hospitals’ new site

23andMe had bad news about my health. I wish a person had delivered it

Listen: Vivek Ramaswamy's star turn & leaky drug data

Wikipedia

FDA advisory panel to debate high blood pressure devices

Study: Spinal cord stimulation helps patients with paralysis walk again

Abortion policy in the spotlight at Republican debate

Kellogg’s is going to war over Mexico’s nutrition label rules

FDA advisory panel to debate high blood pressure devices

Kellogg’s is going to war over Mexico’s nutrition label rules

leisure time

entertainment

focus

leisure time